{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:26:28Z","timestamp":1741926388711,"version":"3.38.0"},"reference-count":44,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2024,7,19]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p> Urinary tract infections (UTI) are responsible for a significant portion of female, outpatient antibiotic prescriptions. Especially true in uncomplicated cases, where symptoms remain the cornerstone of diagnosis, ensuring the optimal choice of agent, dose, and duration may mitigate future bacterial resistance and lower the likelihood of adverse events and\/or recurrence. This study is the first in Canada to examine the quality of antibiotic prescribing to females in the outpatient setting, for uncomplicated UTI\u2013by agent, dose, and duration. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p> All adult female residents of British Columbia with a physician record for cystitis from January 1, 2014, to December 31, 2018, were identified. Patients with a history of urologic abnormalities, spinal cord injury, catheter use, kidney transplant, as well as pregnant females, were excluded. Primary outcomes included the proportion of total episodes prescribed and the proportion of appropriate antibiotic use, examined using Poisson regression. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p> A total of 182,162 episodes of cystitis were examined, with 70% receiving an antibiotic prescription. The rate of cystitis-associated prescribing was 697 prescriptions per 1,000 population. Overall, 35% of prescriptions were appropriate by guideline adherence or clinical justification. Nitrofurantoin and trimethoprim-sulfamethoxazole, accounted for 71% of total antibiotic use. Seven days was the most commonly dispensed duration of therapy, followed by 5, then 10. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p> Shortening length of therapy in line with clinical guidelines and encouraging the use of first line agents present clear, actionable targets for provincial stewardship efforts. <\/jats:p><\/jats:sec>","DOI":"10.3138\/jammi-2023-0031","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T16:38:47Z","timestamp":1717432727000},"page":"61-72","source":"Crossref","is-referenced-by-count":0,"title":["Quality of antibiotic prescribing for outpatient cystitis in adult females"],"prefix":"10.3138","volume":"9","author":[{"given":"Ariana","family":"Saatchi","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Silverman","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Western Ontario, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salimah Z","family":"Shariff","sequence":"additional","affiliation":[{"name":"ICES Western, Lawson Health Research Institute, London Health Sciences Centre, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M","family":"Patrick","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M","family":"Morris","sequence":"additional","affiliation":[{"name":"Sinai Health System, University Health Network and University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer N","family":"Reid","sequence":"additional","affiliation":[{"name":"ICES Western, Lawson Health Research Institute, London Health Sciences Centre, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Povitz","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"McCormack","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawziah Marra","family":"Lalji","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Correspondence: Fawziah Lalji, Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada. Telephone: 604-822-7898."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"issue":"5","key":"r1","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"Gupta K","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"r2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1155\/2008\/404939","volume":"19","author":"McIsaac WJ","year":"2008","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"r3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jgar.2021.11.008","volume":"28","author":"Wagenlehner F","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"r4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bju.15756","volume":"130","author":"Kwok M","year":"2022","journal-title":"Bju Int"},{"issue":"6","key":"r5","doi-asserted-by":"crossref","first-page":"dlac122","DOI":"10.1093\/jacamr\/dlac122","volume":"4","author":"Walkty A","year":"2022","journal-title":"JAC-Antimicrob Resist"},{"issue":"2","key":"r6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/23744235.2020.1834138","volume":"53","author":"Kornf\u00e4lt Isberg H","year":"2021","journal-title":"Infect Dis (Lond)"},{"issue":"665","key":"r7","doi-asserted-by":"crossref","first-page":"e830","DOI":"10.3399\/bjgp17X693641","volume":"67","author":"Butler CC","year":"2017","journal-title":"Br J Gen Pract"},{"key":"r8","doi-asserted-by":"crossref","first-page":"b5633","DOI":"10.1136\/bmj.b5633","volume":"340","author":"Little P","year":"2010","journal-title":"BMJ"},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.3138\/jammi.2019-0023"},{"issue":"3","key":"r10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/00325481.2019.1680052","volume":"132","author":"Bader MS","year":"2020","journal-title":"Postgrad Med"},{"issue":"1","key":"r11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1155\/2011\/745090","volume":"22","author":"McKay RM","year":"2011","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"3","key":"r12","doi-asserted-by":"crossref","first-page":"dlab116","DOI":"10.1093\/jacamr\/dlab116","volume":"3","author":"Saatchi A","year":"2021","journal-title":"JAC-Antimicrob Resist"},{"journal-title":"MOH","year":"2011","author":"British Columbia Ministry of Health","key":"r13"},{"key":"r14","unstructured":"BC Ministry of Health [creator]. PharmaNet. V2. BC Ministry of Health [publisher]. Data extract. Data Stewardship Committee; 2011. http:\/\/www.popdata.bc.ca\/data. https:\/\/www.popdata.bc.ca\/data"},{"volume-title":"Health M of PharmaCare for B.C. Residents - Province of British Columbia","year":"2021","key":"r15"},{"journal-title":"MOH","year":"2011","author":"Canadian Institute for Health Information","key":"r16"},{"issue":"1","key":"r17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12882-022-02899-0","volume":"23","author":"Stolpe S","year":"2022","journal-title":"BMC Nephrol"},{"issue":"1","key":"r18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2369-14-81","volume":"14","author":"Fleet JL","year":"2013","journal-title":"BMC Nephrol"},{"issue":"5","key":"r19","doi-asserted-by":"crossref","first-page":"ITC3","DOI":"10.7326\/0003-4819-156-5-201203060-01003","volume":"156","author":"Gupta K","year":"2012","journal-title":"Ann Intern Med"},{"issue":"10","key":"r20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/cid\/cir637","volume":"53","author":"Gupta K","year":"2011","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"volume-title":"Bugs & drugs: an antimicrobial\/infectious diseases reference","year":"2012","author":"Blondel-Hill E","key":"r21"},{"volume-title":"Antimicrobial Therapy","year":"2017","author":"Gilbert","key":"r22"},{"key":"r23","first-page":"42","volume":"19","author":"Mazzulli T","year":"2012","journal-title":"Can J Urol"},{"issue":"9","key":"r24","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1093\/jac\/dkab205","volume":"76","author":"Rolf von den Baumen T","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"r25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6963-8-12","volume":"8","author":"Li B","year":"2008","journal-title":"BMC Health Serv Res"},{"volume-title":"Cancer data linkage in Manitoba: expanding the infrastructure for research","year":"2016","author":"Lix L","key":"r26"},{"issue":"3","key":"r27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmi.2021.10.013","volume":"28","author":"Knight BD","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"r28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(11)60996-8","volume":"82","author":"Grover ML","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"r29","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s10096-012-1668-9","volume":"31","author":"Denes E","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"issue":"1","key":"r30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s15010-014-0659-4","volume":"43","author":"Kim M","year":"2015","journal-title":"Infection"},{"issue":"9","key":"r31","doi-asserted-by":"crossref","first-page":"ofy198","DOI":"10.1093\/ofid\/ofy198","volume":"5","author":"Durkin MJ","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"r32","doi-asserted-by":"crossref","first-page":"ofz544","DOI":"10.1093\/ofid\/ofz544","volume":"7","author":"Yu JY","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"r33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jcpt.13099","volume":"45","author":"Robinson TF","year":"2020","journal-title":"J Clin Pharm Ther"},{"issue":"50","key":"r34","first-page":"878","volume":"109","author":"Velasco E","year":"2012","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"r35","first-page":"204993612211294","volume":"9","author":"Kon S","year":"2022","journal-title":"Ther Adv Infect Dis"},{"volume-title":"StatPearls","year":"2022","author":"Squadrito FJ","key":"r36"},{"issue":"9","key":"r37","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1503\/cmaj.150067","volume":"187","author":"Singh N","year":"2015","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"issue":"5","key":"r38","first-page":"248","volume":"142","author":"Bains A","year":"2009","journal-title":"Can Pharm J Rev Pharm Can"},{"issue":"9","key":"r39","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00228-013-1520-x","volume":"69","author":"Geerts AFJ","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"r40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2016.04.022","volume":"85","author":"Lob SH","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"r41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1155\/2013\/547848","volume":"24","author":"McIsaac WJ","year":"2013","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"3","key":"r42","doi-asserted-by":"crossref","first-page":"106532","DOI":"10.1016\/j.ijantimicag.2022.106532","volume":"59","author":"Dobbyn D","year":"2022","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"r43","first-page":"CD009534","volume":"4","author":"Zalmanovici Trestioreanu A","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"r44","first-page":"CD009534","volume":"4","author":"Zalmanovici Trestioreanu A","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2023-0031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:37:18Z","timestamp":1741887438000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2023-0031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,7,19]]}},"alternative-id":["10.3138\/jammi-2023-0031"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2023-0031","relation":{},"ISSN":["2371-0888"],"issn-type":[{"type":"electronic","value":"2371-0888"}],"subject":[],"published":{"date-parts":[[2024,7,19]]}}}